Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with some weeks of delay.
Investors invest just under DKK 100m in Danish Visiopharm
August 23, 2018

Visiopharm A/S, which develops software for image analysis of cells for use in cancer diagnostics, has secured a larger investment for further growth. Thus, ATP invests DKK 45m, Vækstfonden DKK 20m and CL Davids Fond DKK 15m. In addition, the existing investor, Northcap Venture Partners, has invested another 15 million.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: